ArticleFish physiology and biochemistry2026
Effects of dietary oxidized soybean meal and oxidized soybean oil on hepatic lipid deposition, antioxidant capacity, inflammation, and apoptosis in blunt snout bream (Megalobrama amblycephala).
Article in Fish physiology and biochemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Soybean meal (SBM) and soybean oil (SO) are important aquafeed ingredients, but both are prone to oxidation. However, few studies have compared the effects of oxidized SBM (OSM) and oxidized SO (OSO) in fish. In this study, OSM and OSO were generated by SBM and SO under the same conditions and then used to evaluate their effects on liver antioxidant capacity, inflammation, and apoptosis in Megalobrama amblycephala. A total of 144 fish (initial body weight: 14.37 ± 0.13 g) were randomly divided into three groups and reared for 8 weeks. Both OSM and OSO increased plasma low-density lipoprotein cholesterol (LDL-C) and decreased high-density lipoprotein cholesterol (HDL-C). Oil Red O staining confirmed hepatic lipid accumulation in both groups. The OSO significantly increased plasma MDA levels, while hepatic protein carbonyl (PC) levels were significantly elevated only in the OSM group. Meanwhile, both treatments significantly increased interleukin-1β (IL-1β) levels and decreased transforming growth factor-β (TGF-β) levels. TUNEL assays confirmed increased hepatocyte apoptosis, associated with the downregulation of pi3k, akt, and nf-κb and changes in caspase family gene expression. Notably, OSO upregulated caspase-8 expression, whereas OSM significantly upregulated caspase-9 and caspase-3 expression, suggesting that OSM may be associated with the regulation of mitochondrial apoptosis-related genes. In conclusion, OSM and OSO induce hepatic lipid accumulation, oxidative stress, and inflammation, and the downregulation of pi3k, akt, and nf-κb expression may be associated with hepatocyte apoptosis. Overall, OSM and OSO exhibited different hepatic response patterns.
Indexed as
Identifiers
42862463What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.